Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reflect strong financial performance, especially in Asia and the U.S., with positive growth metrics and strategic AI investments. The new share buyback program and dividend increase are favorable for shareholders. Despite some challenges in Canada and non-core charges, management's optimistic guidance and execution of strategic plans suggest a positive outlook. The lack of detailed data on the oil price shock impact is a minor concern. Overall, the sentiment is positive, indicating a likely stock price increase in the near term.
Core EPS Grew by 11% year-over-year, reflecting strong growth in core earnings alongside the impact of continued share buybacks.
Core ROE Achieved 16.5%, up 90 basis points from the prior year, driven by strong growth in Asia and share buybacks.
Adjusted Book Value Per Share Increased by 6% year-over-year to $39.01, even as $5.3 billion of capital was returned to shareholders over the past year.
LICAT Ratio Remained strong at 136%, $25 billion above the supervisory target ratio, showcasing financial flexibility.
New Business CSM Grew by 16%, supported by double-digit growth from each insurance segment and strong APE sales growth in Asia and the U.S.
Asia Core Earnings Increased by 22% year-over-year, driven by continued business growth and the net favorable impact of last year's basis change.
APE Sales in Asia Increased by 11% year-over-year, supported by double-digit growth in Hong Kong, Japan, and Singapore.
Global WAM Net Outflows Reported $4.4 billion in net outflows, driven by headwinds in active mutual funds in North America retail and U.S. retirement.
Global WAM Core EBITDA Margin Expanded by 60 basis points year-over-year, supported by AUMA growth, the Comvest acquisition, and expense discipline.
Canada APE Sales Declined by 15% year-over-year, reflecting lower group insurance sales, partially offset by higher individual insurance sales.
Canada Core Earnings Declined by 6% year-over-year, primarily due to unfavorable insurance experience in group insurance and higher expenses.
U.S. APE Sales Grew by 29% year-over-year, driven by strong demand for insurance accumulation products.
U.S. Core Earnings Decreased modestly due to lower investment spreads, partially offset by favorable insurance experience.
AI-powered sales platform: Deployed in U.S. retail, driving a 40% increase in meaningful adviser interactions and supporting higher flows.
Distributor AI tool: Launched in Vietnam and enhanced in Japan to improve agent and adviser productivity.
Quick Quote support tool: Expanded in the U.S., automating nearly half of preliminary assessments and reducing average turnaround time from days to minutes.
Shield Multi-Cancer Detection blood test: Introduced in Asia through a partnership with Guardant Health, offering early cancer detection to eligible customers.
Schroders Indonesia acquisition: Strengthened position as the largest asset manager in Indonesia.
Strategic partnership with L&G: Expanded access to differentiated investment solutions across institutional, retirement, and retail channels.
U.S. distribution footprint expansion: Wholesaling team grew by over 50%, enhancing adviser relationships and market coverage.
AI tools for developers: Increased productivity by 30%, supporting business growth and new capabilities.
AI tools in Asia: Rolled out to enhance agent and adviser productivity, improving customer service and distributor reach.
U.S. Quick Quote tool: Automated nearly half of preliminary assessments, reducing turnaround time significantly.
AI-powered organization: Accelerated progress through partnerships with AKKA and Adaptive ML to deploy AI at scale.
Cancer support programs in Canada: Partnered with Osara Health to offer evidence-based cancer support programs to eligible group benefits customers.
Global WAM Net Outflows: Global Wealth and Asset Management (WAM) experienced net outflows of $4.4 billion, driven by headwinds in active mutual funds in North America retail and U.S. retirement. This could impact revenue and profitability.
Canada Group Insurance Experience: Unfavorable insurance experience in Canada Group insurance, driven by higher incidence and lower recoveries in long-term disability business, along with higher expenses to support business growth and transformational investments.
Market Experience Impact: A $242 million charge in the ALDA portfolio due to lower-than-expected returns across real estate, timber, and private equity investments, alongside a charge from market experience driven by public equity performance.
Economic and Macro Uncertainty: Heightened macroeconomic uncertainty and volatility, which could impact financial performance and strategic execution.
eMPF Transition Impact: The transition to eMPF moderated core earnings growth in Global WAM, creating challenges in maintaining profitability.
U.S. Investment Spreads: Lower investment spreads in the U.S. contributed to a 5% decrease in net investment results, potentially affecting profitability.
Core ROE Target: The company is progressing towards its 18%+ core ROE target by 2027, with a current core ROE of 16.5%, up 90 basis points from the prior year.
Asia Business Growth: Asia delivered 22% year-over-year core earnings growth, supported by strong sales in Hong Kong, Japan, and Singapore. The company expects continued business growth in the region.
Global WAM Segment: The company anticipates a $25 million increase in Q2 core earnings run rate due to reduced one-time expenses and more trading days. Equity market recovery could provide additional tailwinds.
U.S. Segment Growth: APE sales grew 29% year-over-year, driven by strong demand for insurance accumulation products. The company expects continued robust growth in new business CSM.
Capital Return to Shareholders: The company returned $1.2 billion to shareholders in Q1 2026 through dividends and share buybacks, with plans to repurchase up to 2.5% of common shares outstanding under the new buyback program.
Balance Sheet Strength: The LICAT ratio remains strong at 136%, $25 billion above the supervisory target ratio, and the financial leverage ratio is well below the medium-term target of 25%, ensuring financial flexibility.
Dividends: Manulife returned significant capital to shareholders through dividends. Over the past year, $5.3 billion of capital was returned to shareholders, which includes dividends.
Share Buybacks: Manulife continued its share buyback program, repurchasing up to 2.5% of common shares outstanding. During the quarter, $1.2 billion of capital was returned to shareholders through dividends and share buybacks.
The earnings call summary and Q&A reflect strong financial performance, especially in Asia and the U.S., with positive growth metrics and strategic AI investments. The new share buyback program and dividend increase are favorable for shareholders. Despite some challenges in Canada and non-core charges, management's optimistic guidance and execution of strategic plans suggest a positive outlook. The lack of detailed data on the oil price shock impact is a minor concern. Overall, the sentiment is positive, indicating a likely stock price increase in the near term.
The earnings call summary highlights strong financial performance, strategic growth in Asia and Global WAM, and a promising joint venture with Mahindra. The Q&A section reveals management's confidence in achieving core ROE targets and successful capital deployment. Although there are concerns about U.S. mortality and ALDA charges, these are not seen as long-term trends. The company's commitment to completing its NCIB program and strong growth in Japan further support a positive outlook. Overall, the sentiment is positive, with potential for a stock price increase in the coming weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.